PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) - Balzarotti, M.; Ricardi, U.; Spina, M.; Monagheddu, C.; Tucci, A.; Cavallo, F.; Zanni, M.; Arcari, A.; Rusconi, C.; Sartori, R.; Merli, F.; Re, F.; et al.